XYZ Biotech: A Fictional Business Development Case Utilizing Quantitative Tools to Evaluate a New Antibody-Drug-Conjugate Opportunity for Metastatic Breast Cancer. AJM [Internet]. 2023 Dec. 28 [cited 2026 Mar. 16];23(5). Available from: https://articlearchives.co/index.php/AJM/article/view/6109